Cannabis Research

Cannabis Edibles & Breath Tests: What Science Says

mm
Add MyCannabis.com to your preferred sources on Google

A newly published study1 in the Journal of Analytical Toxicology has opened another chapter in the complex conversation about cannabis impairment detection, and it has serious implications for medical patients, veterans, and responsible adult consumers alike. While the research offers intriguing insights into how THC from cannabis-infused edibles appears in the breath, it also underscores a deeper truth: current DUI laws are outdated, inconsistent, and risk harming the very people legalization was meant to protect.

THC Breath Detection Study After Cannabis Edibles

Researchers set out to address a gap in forensic toxicology. While THC detection in breath after smoking or vaping cannabis has been documented, little was known about how THC behaves in breath after oral ingestion, such as edibles.

The team recruited participants, each of whom consumed a cannabis-infused edible, then provided breath samples at four points: before consumption, and at 47, 92, and 180 minutes afterward. Two different breath sampling devices were used to collect the data.

Key findings included:

  • THC was detected in most participants’ breath even before consumption, indicating that residual THC from previous use can appear in results, complicating impairment assessments.
  • Among 19 participants, THC levels peaked at different times: some at 47 minutes, others at 92 minutes, and some as late as 180 minutes post-ingestion.
  • Six participants actually recorded their highest THC concentrations before eating the edible.
  • Four participants showed no significant change in THC levels across the entire testing period.
  • Beyond THC, researchers detected five additional cannabinoids in the breath samples, including CBD. In some participants, CBD levels mirrored THC trends, but in others, they diverged, suggesting different metabolic processing of cannabinoids from edibles.

The study concluded that THC in breath can rise after edible consumption, but also highlighted the significant variability in measurements and the need for more research with longer observation windows.

Next Steps for Cannabis DUI Testing Research

As intriguing as these results are, they should be viewed as proof-of-concept, not definitive science. The authors themselves acknowledge the uncertainty of breath measurement technology and the small sample size. More importantly, the study did not address differences between occasional users, daily users, and long-term medical patients, which is a critical gap when considering public policy (PPHC ).

Without accounting for these differences, any push to use breath detection as a definitive impairment test risks serious injustice. Heavy users, including veterans managing PTSD, chronic pain patients, and people with conditions like multiple sclerosis, often have elevated baseline THC levels without being impaired. For them, THC can remain detectable in breath, blood, and urine for days or even weeks after use, long after the intoxicating effects have worn off.

Outdated Cannabis DUI Laws and Breath Testing Issues

In the United States alone, tens of thousands of people are arrested or imprisoned each year on cannabis-related DUI charges, even in states where cannabis is legal. Many of these individuals are medical patients legally using their prescribed cannabis. Unlike alcohol, where blood alcohol concentration (BAC) directly correlates to impairment, THC levels do not provide a straightforward measure of functional capacity.

This mismatch between science and law creates dangerous consequences. Patients and experienced consumers may face criminal penalties, lose their driver’s licenses, or even their livelihoods, not because they were unsafe to drive, but because testing technology and DUI statutes have failed to adapt to cannabis’ unique pharmacology.

Why a One-Size-Fits-All Cannabis DUI Limit Will Fail

The idea of a universal THC limit for drivers is scientifically flawed. Here’s why:

  • Heavy daily users often have much higher tolerance and can function normally at THC concentrations that would severely impair occasional users.
  • Medical patients may consume cannabis multiple times per day for symptom management, meaning they will always test positive.
  • Occasional consumers may experience pronounced impairment at relatively low THC levels, but breath detection could miss this if the timing doesn’t align with peak levels.

If lawmakers use studies like this one to justify fixed THC limits without considering these differences, they will inevitably criminalize responsible medical use while failing to truly identify impaired drivers.

Swipe to scroll →

User Type Typical THC Breath Levels Impairment Risk Policy Concern
Occasional User Low–Moderate High at low THC levels May pass the test if the peak is missed
Daily Recreational User Moderate–High Low at high THC levels False positives likely
Medical Patient High baseline Variable Criminalization risk despite no impairment

Science-Driven Policy for Cannabis Impairment Detection

What’s needed is a nuanced, evidence-based framework that addresses cannabis impairment in a way that is both fair and effective. This should include:

  • Separate research cohorts for occasional, regular, and medical cannabis users.
  • Impairment-based testing, such as cognitive and motor function assessments, rather than reliance solely on chemical detection.
  • Longitudinal studies tracking breath THC over time for diverse user groups.
  • Veteran- and patient-focused policy input, ensuring that laws do not disproportionately harm vulnerable populations.

This particular study represents a step forward in exploring new detection methods, but it is not, and cannot be, the final say. Until research can reliably distinguish between the presence of THC and actual impairment, breath-based THC testing must be treated with caution.

Final Thoughts

The July 2025 breath detection study is valuable for its contribution to forensic toxicology, especially regarding cannabis edibles, but it also illustrates the complexity of creating fair DUI laws in the age of legalization. Science is still catching up, and without comprehensive research on different user types, implementing blanket laws based on breath THC levels will almost certainly harm the very people cannabis legalization was meant to help.

For now, policymakers should resist the urge to fast-track new roadside testing technology into law without first ensuring it reflects real-world cannabis use patterns. Anything less risks turning the promise of legalization into another chapter of criminalization, only this time, under the guise of public safety.

Studies Referenced:

1. Jennifer L Berry, Ashley Brooks-Russell, Tara M Lovestead, Kavita M Jeerage, The detection of cannabinoids in breath after ingestion of cannabis-infused edibles, Journal of Analytical Toxicology, 2025;, bkaf063, https://doi.org/10.1093/jat/bkaf063

Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.